From Sophie Spitz to Molecular Melanocytoma

How one woman's pioneering research transformed pediatric melanoma diagnosis

By
AlBatool AlMahdy Abdellghaffar
May 7, 2026
4 min

The Pathologist

Objective:

To examine the contributions of Sophie Spitz to the understanding and classification of Spitz nevi and their evolution in dermatopathology.

Key Findings:

Sophie Spitz's 1948 paper transformed the understanding of pediatric melanoma, establishing the term 'Spitz nevus.'
Molecular determinants such as HRAS mutations and kinase fusions have been identified, differentiating Spitz nevi from other melanocytic tumors.
The classification of melanocytoma was solidified in 2022, aligning molecular biology with histology and clinical behavior.

Interpretation:

Spitz's work marked a significant shift in dermatopathology, moving from morphology-based diagnosis to a molecularly integrated approach, improving patient outcomes.

Limitations:

Initial resistance to Spitz's findings delayed acceptance and integration into clinical practice.
Ongoing research is needed to further refine the classification and management of Spitz nevi.

Conclusion:

Sophie Spitz's legacy continues to influence dermatopathology, highlighting the importance of integrating molecular biology into clinical practice for better diagnosis and treatment of melanocytic lesions.

From Sophie Spitz to Molecular Melanocytoma

Objective:

Key Findings:

Interpretation:

Limitations:

Conclusion:

Original Source(s)

From Sophie Spitz to Molecular Melanocytoma

Related Content

Diabetes Risk Scores: Beyond Glucose

ApoB Goal Cost-Effective in Primary Prevention

The Exam Room Is Listening Now